Six challenges in the eradication of infectious diseases

Epidemics

Volumn 10, Issue , 2015, Pages 97-101

  Klepac, Petra ^a   Funk, Sebastian ^b   Hollingsworth, T Deirdre ^c,d   Metcalf, C Jessica E ^e   Hampson, Katie ^f  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^e PRINCETON UNIVERSITY   (United States)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Dynamics; Elimination; Heterogeneity; Modelling; Surveillance

Indexed keywords

COMMUNICABLE DISEASES; COST BENEFIT ANALYSIS; DISEASE ERADICATION; DISEASE PREDISPOSITION; ECONOMICS; HEALTH SURVEY; HUMAN; IMMUNOLOGY; INFECTION CONTROL; PROCEDURES; STATISTICAL MODEL;

COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; COST-BENEFIT ANALYSIS; DISEASE ERADICATION; DISEASE SUSCEPTIBILITY; HUMANS; MODELS, STATISTICAL; POPULATION SURVEILLANCE;

EID: 84926153737     PISSN: 17554365     EISSN: 18780067     Source Type: Journal    
DOI: 10.1016/j.epidem.2014.12.001     Document Type: Article

References (30)

1. Aylward B., Olive J.M., Hull H.F., De Quadros C.A., Melgaard B. Disease eradication initiatives and general health services: ensuring common principles lead to mutual benefits. The Eradication of Infectious Diseases 1998, 61-74. W.R. Dowdle, D. Hopkins (Eds.).
2. Baguelin M., Jit M., Miller E., Edmunds W.J. Health and economic impact of the seasonal influenza vaccination programme in England. Vaccine 2012, 30:3459-3462.
3. Barry M. The tail end of guinea worm-global eradication without a drug or a vaccine. N. Engl. J. Med. 2007, 356:2561-2564.
4. Biswas G., Sankara D.P., Agua-Agum J., Maiga A. Dracunculiasis (guinea worm disease): eradication without a drug or a vaccine. Philos. Trans. R. Soc. B 2013, 368:20120146.
5. Bockarie M.J., Kelly-Hope L.A., Rebollo M., Molyneux D.H. Preventive chemotherapy as a strategy for elimination of neglected tropical parasitic diseases: endgame challenges. Philos. Trans. R. Soc. B 2013, 368:20120144-20120154.
6. Closser S., Rosenthal A., Parris T., Maes K., Justice J., Cox K., et al. Methods for evaluating the impact of vertical programs on health systems: protocol for a study on the impact of the global polio eradication initiative on strengthening routine immunization and primary health care. BMC Public Health 2012, 12:728.
7. Fraser C., Riley S., Anderson R.M., Ferguson N.M. Factors that make an infectious disease outbreak controllable. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:6146-6151.
8. Grassly N.C., Fraser C., Wenger J., Deshpande J.M., Sutter R.W., Heymann D.L., et al. New strategies for the elimination of polio from India. Science 2006, 314:1150-1153.
9. Guerin P.J., Olliaro P., Sundar S., Boelaert M., Croft S.L., Desjeux P., et al. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect. Dis. 2002, 2:494-501.
10. Jansen V., Stollenwerk N., Jensen H., Ramsay M., Edmunds W., Rhodes C. Measles outbreaks in a population with declining vaccine uptake. Science 2003, 301:804-814.
11. Jit M., Choi Y.H., Edmunds W.J. Economic evaluation of human papillomavirus vaccination in the United Kingdom. Br. Med. J. 2008, 337:a769.
12. Klepac P., Laxminarayan R., Grenfell B.T. Synthesizing epidemiological and economic optima for control of immunizing infections. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:14366-14370.
13. Klepac P., Metcalf C.J.E., McLean A., Hampson K. Towards the endgame and beyond: complexities and challenges for the elimination of infectious diseases. Philos. Trans. R. Soc. B 2013, 368:20120137.
14. Lessler J., Metcalf C.J.E., Grais R.F., Luquero F.J., Cummings D.A.T., Grenfell B.T. Measuring the performance of vaccination programs using cross-sectional surveys: a likelihood framework and retrospective analysis. PLoS Med. [Internet] 2011, 8:e1001110. Available from: http://dx.plos.org/10.1371/journal.pmed.1001110.g003.
15. Lloyd-Smith J.O. Vacated niches, competitive release and the community ecology of pathogen eradication. Philos. Trans. R. Soc. B 2013, 368:20120150.
16. McLean A.R., Anderson R.M. Measles in developing countries. Part II. The predicted impact of mass vaccination. Epidemiol. Infect. 1988, 100:419-442.
17. Metcalf C.J.E., Hampson K., Tatem A.J., Grenfell B.T., Bjornstad O.N. Persistence in epidemic metapopulations: quantifying the rescue effects for measles, mumps. rubella and whooping cough. PLOS ONE 2013, 8:e74696.
18. O'Reilly K.M., Chauvin C., Aylward R.B., Maher C., Okiror S., Wolff C., et al. A statistical model of the international spread of wild poliovirus in Africa used to predict and prevent outbreaks. PLoS Med. 2011, 8:e1001109.
19. Sabot O., Cohen J.M., Hsiang M.S., Kahn J.G., Basu S., Tang L., et al. Costs and financial feasibility of malaria elimination. Lancet 2010, 376:1604-1615.
20. Saint-Victor D.S., Omer S.B. Vaccine refusal and the endgame: walking the last mile first. Philos. Trans. R. Soc. B 2013, 368:20120148.
21. Simons E., Ferrari M., Fricks J., Wannemuehler K., Anand A., Burton A., et al. Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. Lancet 2012, 379:2173-2178.
22. Smith D.L., Cohen J.M., Chiyaka C., Johnston G., Gething P.W., Gosling R., et al. A sticky situation: the unexpected stability of malaria elimination. Philos. Trans. R. Soc. B: Biol. Sci. 2013, 368:20120145.
23. Snow R.W., Omumbo J.A., Lowe B., Molyneux C.S. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet 1997, 349:1650-1654.
24. Tatem A.J., Qiu Y., Smith D.L., Sabot O., Ali A.S., Moonen B. The use of mobile phone data for the estimation of the travel patterns and imported Plasmodium falciparum rates among Zanzibar residents. Malar. J. 2009, 8:287.
25. Townsend S.E., Sumantra I.P., Pudjiatmoko, Bagus G.N., Brum E., Cleaveland S., et al. Designing programs for eliminating canine rabies from islands: Bali, Indonesia as a case study. PLoS Negl. Trop. Dis. 2013, 7:e2372.
26. Townsend S.E., Lembo T., Cleaveland S., Meslin F.X., Miranda M.E., Putra A.A.G., et al. Surveillance guidelines for disease elimination: a case study of canine rabies. Comp. Immunol. Microbiol. Infect. Dis. 2013, 36:249-261.
27. India Three Years Polio-free [Internet] 2014, (cited 2014 Feb 28). Available from: http://www.searo.who.int/mediacentre/features/2014/sea-polio/en/. WHO (Ed.).
28. Wise J. Largest group of children affected by measles outbreak in Wales is 10-18 year olds. BMJ 2013, 346:f2545-f2555.
29. Woolhouse M.E.J. Theory and Practice of Disease Surveillance [Internet] 2013, Available from: http://www.newton.ac.uk/programmes/IDD/seminars/2013082110001.html.
30. World Health Organization Malaria Elimination: A Field Manual for Low and Moderate Endemic Countries 2007.